Importance and application of WES in fetal genetic diagnostics: Identification of novel

ASPM Microcephaly Prenatal WES

Journal

Molecular genetics and metabolism reports
ISSN: 2214-4269
Titre abrégé: Mol Genet Metab Rep
Pays: United States
ID NLM: 101624422

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 17 08 2023
revised: 10 01 2024
accepted: 15 01 2024
medline: 12 3 2024
pubmed: 12 3 2024
entrez: 12 3 2024
Statut: epublish

Résumé

Prenatal whole exome sequencing (WES) approaches can provide genetic diagnosis with rapid turnaround time and high diagnostic rate when conventional tests are negative. Here we report a family with multiple pregnancy loss and with repeated occurrence of fetal microcephaly. Because of positive family history and recurrent structural abnormality during the pregnancies that may lead postnatal neurodevelopmental consequences, WES analysis was indicated. Umbilical cord blood sampling was carried out and WES was performed using Twist Human Core Exome Kit and Illumina sequencing technology. The presence of pathogenic variants was confirmed by Sanger sequencing. WES analysis revealed a known pathogenic c.8506_8507delCA (p.Gln2836Glufs*35, rs587783280) and a novel pathogenic c.3134_3135delTC (p.Leu1045Glnfs*17) Our findings serve additional evidence that WES can be an efficient and relevant tool to diagnose certain genetic disorders with appropriate indication and to assess the recurrence risk of a disease. With the application of WES in combination with pre-implantation genetic tests, we can avoid the transmission of pathogenic mutations and we can achieve a decreased abortion rate in obstetric care.

Sections du résumé

Background UNASSIGNED
Prenatal whole exome sequencing (WES) approaches can provide genetic diagnosis with rapid turnaround time and high diagnostic rate when conventional tests are negative. Here we report a family with multiple pregnancy loss and with repeated occurrence of fetal microcephaly.
Methods and results UNASSIGNED
Because of positive family history and recurrent structural abnormality during the pregnancies that may lead postnatal neurodevelopmental consequences, WES analysis was indicated. Umbilical cord blood sampling was carried out and WES was performed using Twist Human Core Exome Kit and Illumina sequencing technology. The presence of pathogenic variants was confirmed by Sanger sequencing. WES analysis revealed a known pathogenic c.8506_8507delCA (p.Gln2836Glufs*35, rs587783280) and a novel pathogenic c.3134_3135delTC (p.Leu1045Glnfs*17)
Conclusions UNASSIGNED
Our findings serve additional evidence that WES can be an efficient and relevant tool to diagnose certain genetic disorders with appropriate indication and to assess the recurrence risk of a disease. With the application of WES in combination with pre-implantation genetic tests, we can avoid the transmission of pathogenic mutations and we can achieve a decreased abortion rate in obstetric care.

Identifiants

pubmed: 38469100
doi: 10.1016/j.ymgmr.2024.101056
pii: S2214-4269(24)00009-0
pmc: PMC10926227
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101056

Informations de copyright

© 2024 The Authors. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

None.

Auteurs

Renata Szalai (R)

University of Pecs, Medical School, Department of Medical Genetics, Pecs, Hungary.

Agnes Till (A)

University of Pecs, Medical School, Department of Medical Genetics, Pecs, Hungary.

Attila Gyenesei (A)

Szentagothai Research Center, University of Pecs, Pecs, Hungary.

Judit Bene (J)

University of Pecs, Medical School, Department of Medical Genetics, Pecs, Hungary.

Kinga Hadzsiev (K)

University of Pecs, Medical School, Department of Medical Genetics, Pecs, Hungary.

Classifications MeSH